| abstract |
This invention relates to novel therapeutic uses of beta-adrenergic agonists in humans and animals. The uses include increasing muscle growth and reducing fat uptake from dietary input, retarding or reversing atrophy of denervated muscle, alleviating or reversing the effects of various diseases (including cancer), modification of foetal and neonatal growth, and possible genetic modifications of the developing foetus. The preferred beta-adrenergic agonist is clenbuterol. Surprisingly, the beta-adrenergic agonist can be mixed with a beta-adrenergic antagonist to obviate or mitigate unwanted side-effects without excessively inhibiting the wanted novel effects. |